| 1 |
LEE Y, RIO D C. Mechanisms and regulation of alternative pre-mRNA splicing[J]. Annu. Rev. Biochem., 2015, 84: 291-323.
|
| 2 |
MERKIN J, RUSSELL C, CHEN P, et al.. Evolutionary dynamics of gene and isoform regulation in mammalian tissues[J]. Science, 2012, 338(6114): 1593-1599.
|
| 3 |
MILLEVOI S, DECORSIÈRE A, LOULERGUE C, et al.. A physical and functional link between splicing factors promotes pre-mRNA 3' end processing[J]. Nucleic Acids Res., 2009, 37(14): 4672-4683.
|
| 4 |
CASTELO-BRANCO P, FURGER A, WOLLERTON M, et al.. Polypyrimidine tract binding protein modulates efficiency of polyadenylation[J]. Mol. Cell. Biol., 2004, 24(10): 4174-4183.
|
| 5 |
JACKSON R J, KAMINSKI A. Internal initiation of translation in eukaryotes: the picornavirus paradigm and beyond[J]. RNA, 1995, 1(10): 985-1000.
|
| 6 |
KAMINSKI A, HUNT S L, PATTON J G, et al.. Direct evidence that polypyrimidine tract binding protein (PTB) is essential for internal initiation of translation of encephalomyocarditis virus RNA[J]. RNA, 1995, 1(9): 924-938.
|
| 7 |
GAMA-CARVALHO M, BARBOSA-MORAIS N L, BRODSKY A S, et al.. Genome-wide identification of functionally distinct subsets of cellular mRNAs associated with two nucleocytoplasmic-shuttling mammalian splicing factors[J/OL]. Genome Biol., 2006, 7(11): R113[2024-12-10]. .
|
| 8 |
COELHO M B, ASCHER D B, GOODING C, et al.. Functional interactions between polypyrimidine tract binding protein and PRI peptide ligand containing proteins[J]. Biochem. Soc. Trans., 2016, 44(4): 1058-1065.
|
| 9 |
LIU J, LI Y, TONG J, et al.. Long non-coding RNA-dependent mechanism to regulate heme biosynthesis and erythrocyte development[J/OL]. Nat. Commun., 2018, 9: 4386[2024-12-10]. .
|
| 10 |
SUCKALE J, WENDLING O, MASJKUR J, et al.. PTBP1 is required for embryonic development before gastrulation[J/OL]. PLoS One, 2011, 6(2): e16992[2024-12-10]. .
|
| 11 |
SHIBAYAMA M, OHNO S, OSAKA T, et al.. Polypyrimidine tract-binding protein is essential for early mouse development and embryonic stem cell proliferation[J]. FEBS J., 2009, 276(22): 6658-6668.
|
| 12 |
REHN M, WENZEL A, A-KFRANK, et al.. PTBP1 promotes hematopoietic stem cell maintenance and red blood cell development by ensuring sufficient availability of ribosomal constituents[J/OL]. Cell Rep., 2022, 39(6): 110793[2024-12-10]. .
|
| 13 |
NEWTON K, WICKLIFFE K E, DUGGER D L, et al.. Cleavage of RIPK1 by caspase-8 is crucial for limiting apoptosis and necroptosis[J]. Nature, 2019, 574(7778): 428-431.
|
| 14 |
IWAMORI N, TOMINAGA K, SATO T, et al.. MRG15 is required for pre-mRNA splicing and spermatogenesis[J/OL]. Proc. Natl. Acad. Sci. USA, 2016, 113(37): 1611995113 [2024-12-10]. .
|
| 15 |
TAHMASEBI S, JAFARNEJAD S M, TAM I S, et al.. Control of embryonic stem cell self-renewal and differentiation via coordinated alternative splicing and translation of YY2[J]. Proc. Natl. Acad. Sci. USA, 2016, 113(44): 12360-12367.
|
| 16 |
ALDAVE G, GONZALEZ-HUARRIZ M, RUBIO A, et al.. The aberrant splicing of BAF45d links splicing regulation and transcription in glioblastoma[J]. Neuro Oncol., 2018, 20(7): 930-941.
|
| 17 |
GRIDLEY T, GROVES A K. Overview of genetic tools and techniques to study Notch signaling in mice[J]. Methods Mol. Biol., 2014, 1187: 47-61.
|
| 18 |
WENDORFF A A, FERRANDO A A. Modeling NOTCH1 driven T-cell acute lymphoblastic leukemia in mice[J/OL]. Bio. Protoc., 2020, 10(10): e3620[2024-12-10]. .
|
| 19 |
XING L, GUO X, ZHANG X, et al.. PTBP1 is a potential indicator of disease progression in acute myeloid leukaemia[J/OL]. J. Investig. Med. Off. Publ. Am. Fed. Clin. Res., 2024, 10815589241264783[2024-12-15]. .
|
| 20 |
ZIEGLER N, CORTÉS-LÓPEZ M, ALT F, et al.. Analysis of RBP expression and binding sites identifies PTBP1 as a regulator of CD19 expression in B-ALL[J/OL]. Oncoimmunology, 2023, 12(1): 2184143[2024-12-10]. .
|
| 21 |
黄琬玲,朱文琦,郭妮妮,等.NRG4基因对急性髓系白血病细胞增殖、凋亡及周期的影响[J].生物技术进展,2023,13(2):305-310.
|
|
HUANG W L, ZHU W Q, GUO N N, et al.. Effects of NRG4 on proliferation, apoptosis and cell cycle of acute myeloid leukemia cells[J]. Curr. Biotechnol., 2023, 13(2): 305-310.
|
| 22 |
LA PORTA J, MATUS-NICODEMOS R, VALENTÍN-ACEVEDO A, et al.. The RNA-binding protein, polypyrimidine tract-binding protein 1 (PTBP1) is a key regulator of CD4 T cell activation[J/OL]. PLoS One, 2016, 11(8): e0158708[2024-12-10]. .
|
| 23 |
MARASCA S S, VADALA R, et al.. LINE1 are spliced in non-canonical transcript variants to regulate T cell quiescence and exhaustion[J]. Nat. Genet., 2022, 54:180-193.
|
| 24 |
LI T, GAO R, XU K, et al.. BCL7A inhibits the progression and drug-resistance in acute myeloid leukemia[J/OL]. Drug Resist. Updat., 2024, 76: 101120[2024-12-10]. .
|
| 25 |
ZHANG Q X, PAN Y M, XIAO H L, et al.. Alternative splicing analysis showed the splicing factor polypyrimidine tract-binding protein 1 as a potential target in acute myeloid leukemia therapy[J]. Neoplasma, 2022, 69(5): 1198-1208.
|
| 26 |
WANG L, YANG L, YANG Z, et al.. Glycolytic enzyme PKM2 mediates autophagic activation to promote cell survival in NPM1-mutated leukemia[J]. Int. J. Biol. Sci., 2019, 15(4): 882-894.
|
| 27 |
BAI H, CHEN B. Abnormal PTBP1 expression sustains the disease progression of multiple myeloma[J/OL]. Dis. Markers, 2020, 2020: 4013658[2024-12-10]. .
|